CSIMarket Company Name, Ticker, Suppliers, else..


Sarepta Therapeutics Inc   (NASDAQ: SRPT)
Other Ticker:  
 

Sarepta Therapeutics Inc

SRPT's Fundamental analysis



Looking into Sarepta Therapeutics Inc growth rates, revenue grew by 65.94 % in IV. Quarter 2024 from the same quarter a year ago. Ranking at No. 570

Major Pharmaceutical Preparations industry recorded growth of revenues by 11.99 %

Sarepta Therapeutics Inc 's net income grew by 248.37 % in IV. Quarter 2024 year on year, above company average,

• More on SRPT's Growth


Sarepta Therapeutics Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Sarepta Therapeutics Inc PEG ratio is at -0.3 Company is currently trading with Price to Cash flow multiple of 10.95 in trailing twelve-month period.
Company
39.03
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 3.88.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.41.


• More on SRPT's Valuation
 
 Total Debt (Millions $) 1,137
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 1,447,473
 Net Income/Employee (TTM) $ 179,025
 Receivable Turnover (TTM) 4.29
 Tangible Book Value (Per Share $) 15.20

Sarepta Therapeutics Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Sarepta Therapeutics Inc PEG ratio is at -0.3 Company is currently trading with Price to Cash flow multiple of 10.95 in trailing twelve-month period.
Company
39.03
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 3.88.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.41.

Sarepta Therapeutics Inc Price to Book Ratio is at 4.83 lower than Industry Avg. of 91.79. and higher than S&P 500 Avg. of 0.01

• More on SRPT's Valuation

•  Market Capitalization (Millions $) 7,384
•  Shares Outstanding (Millions) 101
•  Employees 1,314
•  Revenues (TTM) (Millions $) 1,902
•  Net Income (TTM) (Millions $) 235
•  Cash Flow (TTM) (Millions $) 675
•  Capital Exp. (TTM) (Millions $) -147
•  Total Debt (Millions $) 1,137
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 1,447,473
•  Net Income/Employee(TTM) $ 179,025
•  Receivable Turnover Ratio (TTM) 4.29
•  Tangible Book Value (Per Share $) 15.20

•  Market Capitalization (Millions $) 7,384
•  Shares Outstanding (Millions) 101
•  Employees 1,314
•  Revenues (TTM) (Millions $) 1,902
•  Net Income (TTM) (Millions $) 235
•  Cash Flow (TTM) (Millions $) 675
•  Capital Exp. (TTM) (Millions $) -147


    SRPT's Profitability Comparisons
Sarepta Therapeutics Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2024 to 24.56 % from 4.75 % in III. Quarter.

Sarepta Therapeutics Inc net profit margin of 24.16 % is currently ranking no. 25 in Major Pharmaceutical Preparations industry, ranking no. 44 in Healthcare sector and number 535 in S&P 500.


Profitability by Segment
Total 7.19 %



  Ratio
•   Capital Ratio (MRQ) 5.11
•  Total Debt to Equity (MRQ) 0.74
•  Tangible Leverage Ratio (MRQ) 1.51
•  Asset Turnover Ratio (TTM) 0.56
•  Inventory Turnover Ratio (TTM) -



Sarepta Therapeutics Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2024 to 24.56 % from 4.75 % in III. Quarter.

Sarepta Therapeutics Inc net profit margin of 24.16 % is currently ranking no. 25 in Major Pharmaceutical Preparations industry, ranking no. 44 in Healthcare sector and number 535 in S&P 500.

• More on SRPT's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com